These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31974612)

  • 1. SHOC2 is associated with the survival of breast cancer cells and has prognostic value for patients with breast cancer.
    Geng W; Dong K; Pu Q; Lv Y; Gao H
    Mol Med Rep; 2020 Feb; 21(2):867-875. PubMed ID: 31974612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SHOC2 scaffold protein modulates daunorubicin-induced cell death through p53 modulation in lymphoid leukemia cells.
    Silveira VS; Borges KS; Santos VS; Ruckert MT; Vieira GM; Vasconcelos EJR; Nagano LFP; Tone LG; Scrideli CA
    Sci Rep; 2020 Sep; 10(1):15193. PubMed ID: 32938995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Leucine-Rich Repeat Protein Provides a SHOC2 the RAS Circuit: a Structure-Function Perspective.
    Kwon JJ; Hahn WC
    Mol Cell Biol; 2021 Mar; 41(4):. PubMed ID: 33526449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skp2 is over-expressed in breast cancer and promotes breast cancer cell proliferation.
    Zhang W; Cao L; Sun Z; Xu J; Tang L; Chen W; Luo J; Yang F; Wang Y; Guan X
    Cell Cycle; 2016 May; 15(10):1344-51. PubMed ID: 27111245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.
    Yuan SS; Hou MF; Hsieh YC; Huang CY; Lee YC; Chen YJ; Lo S
    J Natl Cancer Inst; 2012 Oct; 104(19):1485-502. PubMed ID: 22914783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SHOC2 subcellular shuttling requires the KEKE motif-rich region and N-terminal leucine-rich repeat domain and impacts on ERK signalling.
    Motta M; Chillemi G; Fodale V; Cecchetti S; Coppola S; Stipo S; Cordeddu V; Macioce P; Gelb BD; Tartaglia M
    Hum Mol Genet; 2016 Sep; 25(17):3824-3835. PubMed ID: 27466182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance.
    Zeng C; Ke Z; Song Y; Yao Y; Hu X; Zhang M; Li H; Yin J
    Exp Mol Pathol; 2013 Aug; 95(1):23-31. PubMed ID: 23631820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FBXW7-SHOC2-Raptor Axis Controls the Cross-Talks between the RAS-ERK and mTORC1 Signaling Pathways.
    Xie CM; Tan M; Lin XT; Wu D; Jiang Y; Tan Y; Li H; Ma Y; Xiong X; Sun Y
    Cell Rep; 2019 Mar; 26(11):3037-3050.e4. PubMed ID: 30865892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and functional characterization of a novel RASopathy-causing SHOC2 mutation associated with prenatal-onset hypertrophic cardiomyopathy.
    Motta M; Giancotti A; Mastromoro G; Chandramouli B; Pinna V; Pantaleoni F; Di Giosaffatte N; Petrini S; Mazza T; D'Ambrosio V; Versacci P; Ventriglia F; Chillemi G; Pizzuti A; Tartaglia M; De Luca A
    Hum Mutat; 2019 Aug; 40(8):1046-1056. PubMed ID: 31059601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global characterization of signalling networks associated with tamoxifen resistance in breast cancer.
    Browne BC; Hochgräfe F; Wu J; Millar EK; Barraclough J; Stone A; McCloy RA; Lee CS; Roberts C; Ali NA; Boulghourjian A; Schmich F; Linding R; Farrow L; Gee JM; Nicholson RI; O'Toole SA; Sutherland RL; Musgrove EA; Butt AJ; Daly RJ
    FEBS J; 2013 Nov; 280(21):5237-57. PubMed ID: 23876235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
    Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
    Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA BANCR indicates poor prognosis for breast cancer and promotes cell proliferation and invasion.
    Lou KX; Li ZH; Wang P; Liu Z; Chen Y; Wang XL; Cui HX
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1358-1365. PubMed ID: 29565494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
    Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
    Tang J; Deng R; Luo RZ; Shen GP; Cai MY; Du ZM; Jiang S; Yang MT; Fu JH; Zhu XF
    Breast Cancer Res Treat; 2012 Jul; 134(2):549-60. PubMed ID: 22585231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of Ran GTPase expression inhibits the proliferation and migration of breast cancer cells.
    Sheng C; Qiu J; Wang Y; He Z; Wang H; Wang Q; Huang Y; Zhu L; Shi F; Chen Y; Xiong S; Xu Z; Ni Q
    Mol Med Rep; 2018 Jul; 18(1):157-168. PubMed ID: 29750309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
    He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
    Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADA3 regulates normal and tumor mammary epithelial cell proliferation through c-MYC.
    Griffin NI; Sharma G; Zhao X; Mirza S; Srivastava S; Dave BJ; Aleskandarany M; Rakha E; Mohibi S; Band H; Band V
    Breast Cancer Res; 2016 Nov; 18(1):113. PubMed ID: 27852327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells.
    Yao Z; Zheng X; Lu S; He Z; Miao Y; Huang H; Chu X; Cai C; Zou F
    Breast Cancer; 2019 Nov; 26(6):835-845. PubMed ID: 31264076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shoc2/Sur8 protein regulates neurite outgrowth.
    Leon G; Sanchez-Ruiloba L; Perez-Rodriguez A; Gragera T; Martinez N; Hernandez S; Anta B; Calero O; Garcia-Dominguez CA; Dura LM; Peña-Jimenez D; Castro J; Zarich N; Sanchez-Gomez P; Calero M; Iglesias T; Oliva JL; Rojas JM
    PLoS One; 2014; 9(12):e114837. PubMed ID: 25514808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers.
    Jones GG; Del Río IB; Sari S; Sekerim A; Young LC; Hartig N; Areso Zubiaur I; El-Bahrawy MA; Hynds RE; Lei W; Molina-Arcas M; Downward J; Rodriguez-Viciana P
    Nat Commun; 2019 Jun; 10(1):2532. PubMed ID: 31182717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.